Literature DB >> 15370126

Tissue microarrays: a practical guide.

Beena Kumar1, Melanie De Silva, Deon J Venter, Jane E Armes.   

Abstract

Tissue microarrays are a recent innovation in the field of pathology. They were originally designed as a high-throughput approach for researchers to assess the expression of interesting candidate disease-related genes or gene products simultaneously on hundreds of tissue samples. However, their use is becoming more widespread in routine pathology, for example for quality assurance and for the optimisation of diagnostic reagents such as monoclonal antibodies and gene probes. Several molecular and conventional pathological techniques can be performed on a single tissue array, thereby enabling morphology, DNA, RNA and protein targets to be analysed on sequential sections through multiple tissue samples. Moreover, compared with full-face tissue sections, tissue microarrays are a cost- and time-efficient, effective approach to analysing biomarker expression on a large number of samples. Whilst tissue microarrays are available from commercial sources, many pathology laboratories prefer to make in-house arrays from their often extensive pathology archive to facilitate the correlation of their findings with clinical parameters. The technical skills necessary to produce tissue arrays are well within the capacity of most laboratories. However, several pitfalls to successful array production exist. The present article describes the applications of this technique and details practical points for optimal tissue array production.

Mesh:

Year:  2004        PMID: 15370126     DOI: 10.1080/00313020410001721555

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  3 in total

1.  ROS1 expression in invasive ductal carcinoma of the breast related to proliferation activity.

Authors:  Minseob Eom; Sayamaa Lkhagvadorj; Sung Soo Oh; Airi Han; Kwang Hwa Park
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

Review 2.  Tissue Microarray: A rapidly evolving diagnostic and research tool.

Authors:  Nazar M T Jawhar
Journal:  Ann Saudi Med       Date:  2009 Mar-Apr       Impact factor: 1.526

3.  Cell line and patient-derived xenograft models reveal elevated CDCP1 as a target in high-grade serous ovarian cancer.

Authors:  Brittney S Harrington; Yaowu He; Claire M Davies; Sarah J Wallace; Mark N Adams; Elizabeth A Beaven; Deborah K Roche; Catherine Kennedy; Naven P Chetty; Alexander J Crandon; Christopher Flatley; Niara B Oliveira; Catherine M Shannon; Anna deFazio; Anna V Tinker; C Blake Gilks; Brian Gabrielli; Donal J Brennan; Jermaine I Coward; Jane E Armes; Lewis C Perrin; John D Hooper
Journal:  Br J Cancer       Date:  2016-02-04       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.